• Health & Medicine

One-off PSA screening for prostate cancer does not save lives

Inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives according to results from the largest ever prostate cancer trial. Inviting men with no symptoms to a one-off PSA test for prostate cancer does not save lives according to results from the largest ever prostate cancer trial.

6 March 2018

• Science & Technology

Aggressive brain tumours carry potential target for engineered immune cells

A molecule on glioblastoma cells that could be used as a target for genetically engineered immune cells has been identified. A molecule on glioblastoma cells that could be used as a target for genetically engineered immune cells has been identified.

1 March 2018

• Health & Medicine

Millennials top obesity chart before reaching middle age

More than seven in 10 millennials – those born between the early 80s and mid 90s – are set to be overweight or obese between the ages of 35-44. More than seven in 10 millennials – those born between the early 80s and mid 90s – are set to be overweight or obese between the ages of 35-44.

26 February 2018

• Health & Medicine

Three thyroid cancer drugs approved for NHS in England

Three thyroid cancer treatments have been approved for routine use on the NHS in England. Three thyroid cancer treatments have been approved for routine use on the NHS in England.

23 February 2018

• Health & Medicine

Lab-grown ‘mini tumours’ could personalise cancer treatment

Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tailor treatment, according to new research. Testing cancer drugs on miniature replicas of a patient’s tumour could help doctors tailor treatment, according to new research.

22 February 2018

• For Supporters

Patients to benefit from new brain cancer research funding boost

Brain tumour research in the UK is set to be revolutionised with £45 million in funding by the Department of Health and Social Care and Cancer Research UK. Brain tumour research in the UK is set to be revolutionised with £45 million in funding by the Department of Health and Social Care and Cancer Research UK.

22 February 2018

• Charity News

Cancer Research UK appoints leading expert to help accelerate advancements in clinical research

Cancer Research UK announces the appointment of Dr James Larkin as a new Senior Clinical Advisor in clinical research. Cancer Research UK announces the appointment of Dr James Larkin as a new Senior Clinical Advisor in clinical research.

20 February 2018

• Health & Medicine

Breast cancer relapse tests vary in accuracy

Branded tests designed to predict if breast cancer will come back vary in accuracy, according to a new study. Branded tests designed to predict if breast cancer will come back vary in accuracy, according to a new study.

16 February 2018

• Health & Medicine

Drugs approved in Scotland for bladder and skin cancers

Two new cancer drugs have been approved for use on the NHS in Scotland. Two new cancer drugs have been approved for use on the NHS in Scotland.

15 February 2018

• Health & Medicine

Cancer Research UK to invest £45 million in clinical trials

Cancer Research UK has announced that £45 million will be invested into its network of clinical trials units across the UK. Cancer Research UK has announced that £45 million will be invested into its network of clinical trials units across the UK.

15 February 2018

• Health & Medicine

Scans could help tailor pancreatic cancer treatment

Doctors should use a specialised type of scan to help decide if patients with pancreatic cancer may benefit from surgery, according to NICE. Doctors should use a specialised type of scan to help decide if patients with pancreatic cancer may benefit from surgery, according to NICE.

9 February 2018

• Health & Medicine

Apalutamide delays spread of certain prostate cancers in trial

An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results. An experimental hormone therapy delays the spread of prostate cancer that has stopped responding to standard treatment, according to new clinical trial results.

9 February 2018